HIV drug stabilizes disease progression in metastatic colorectal cancer - EurekAlert
Many cancers exhibit high levels of the reverse transcriptase enzyme. Single-agent lamivudine, a reverse transcriptase inhibitor, stopped disease progression in over 25% of patients with fourth-line refractory metastatic colorectal cancer. These results provi…
BOSTON — New clinical research shows that lamivudine, a reverse transcriptase inhibitor widely used in HIV therapy, stopped disease progression in 25% of patients with fourth-line metastatic colorect… [+5518 chars]
Read More
Other Stories in Health
- USAMRAA grant supports COPD biosensor project at The Lundquist Institute
- Breast cancer survivors at higher risk of developing second cancers
- World Malaria Day 2024: Health tips for quick recovery
- IBS Diet: 6 food items should be avoided
- Opioids more potent than fentanyl have been detected in Australia. So what are nitazenes?
- Where would you attend? Yale v Vanderbilt
- We Must Demolish NP Diploma Mills
- 7 effective ways to lose weight without going to gym
- Seattle Children's August 2024 Residency
.png)
